Showing results (41-50 of 574) with videos related to
Sort By:
Pageof 58
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 14, 1999
Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitusA Festa, N Shnawa, G Schernthaner, et al.International Journal of Obesity|July 1, 1991
Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal womenS M Haffner, M S Katz, J F DunnDiabetes, Obesity & Metabolism|January 25, 2012
Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysisM Pendergrass, C Fenton, S M Haffner, et al.Metabolism: Clinical and Experimental|October 1, 1987
The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterolD Applebaum-Bowden, S M Haffner, W R HazzardDiabetes Care|April 1, 1991
Decrease of lipoprotein(a) with improved glycemic control in IDDM subjectsS M Haffner, K R Tuttle, D L RainwaterEndocrine Research|January 1, 1990
The relationship of insulin sensitivity and metabolic clearance of insulin to adiposity and sex hormone binding globulinS M Haffner, M S Katz, J F DunnMetabolism: Clinical and Experimental|March 1, 1992
Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 patternS M Haffner, R S Kushwaha, W R HazzardDiabetologia|July 1, 1997
Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes StudyS M Haffner, C Gonzalez, L Mykkänen, et al.Diabetes|February 1, 1994
Insulin resistance, body fat distribution, and sex hormones in menS M Haffner, P Karhapää, L Mykkänen, et al.European Journal of Clinical Investigation|October 1, 1989
Metabolism of chylomicrons in subjects with dysbetalipoproteinaemia (type III hyperlipoproteinaemia)S M Haffner, R S Kushwaha, W R HazzardPageof 58